Immune system development in infants born to mothers with autoimmune disease, exposed in utero to immunosuppressive agents

American Journal of Perinatology

Volumn 24, Issue 8, 2007, Pages 441-447

  Motta, Mario ^a,d   Ciardelli, Laura ^b   Marconi, Massimo ^b   Tincani, Angela ^c   Gasparoni, Antonella ^a   Lojacono, Andrea ^c   Chirico, Gaetano ^a  

^a NICU   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c NONE   (Italy)

^d Neonatal Intensive Care Unit   (Italy)

Author keywords

Autoimmune disease; Immune system; Immunosuppressive agents; Infant

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CYCLOSPORIN A; GLUCOCORTICOID; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE;

ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BIRTH WEIGHT; BLOOD CELL COUNT; CELL ISOLATION; CONNECTIVE TISSUE DISEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE SYSTEM; IMMUNOGLOBULIN PRODUCTION; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE COUNT; MATERNAL DISEASE; MONOTHERAPY; NORMAL HUMAN; PHENOTYPE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RHEUMATIC DISEASE; STATISTICAL ANALYSIS; T LYMPHOCYTE;

AUTOIMMUNE DISEASES; AZATHIOPRINE; CYCLOSPORINE; FEMALE; HUMANS; HYDROXYCHLOROQUINE; IMMUNE SYSTEM; IMMUNOGLOBULIN ISOTYPES; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES;

EID: 35148872630     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-986679     Document Type: Article

References (30)

1. Motta M, Tincani A, Lojacono A, et al. Neonatal outcome in patients with rheumatic disease. Lupus 2004;13:718-723
2. Prevot A, Martini S, Guignard JP. In utero exposure to immunosuppressive drugs. Biol Neonate 2002;81:73-81
3. Scott JR. Risks to the children born to mothers with autoimmune diseases. Lupus 2002;11:655-660
4. Rose ML, Dominguez M, Levare N. Analysis of T cell subpopulations and cyclosporine levels in the blood of two neonates born to immunosuppressed heart-lung transplant recipients. Transplantation 1989;48:223-226
5. Ersay A, Oygür N, Cpskun M, Süleymanlar G, Track B, Yegin O. Immunologic evaluation of a neonate born to an immunosuppressed kidney transplant recipient. Am J Perinatal 1995;12:413-415
6. Takahashi N, Nishida H, Hoshi J. Severe B cell depletion in newborns from renal transplant mothers taking immunosuppressive agents. Transplantation 1994;57:1617-1621
7. Baarsma R, Kamps WA. Immunological responses in an infant after cyclosporine A exposure during pregnancy. Eur J Pediatr 1993;152:476-477
8. Kozlowska-Boszko B, Korczak G, Wierzbicki P, et al. Pregnancy following kidney transplantation: risk for off-springs. Transplant Proc 1997;29:262-265
9. Di Paolo S, Schena A, Morrone LF, et al. Immunologic evaluation during the first year of life of infants born to cyclosporine-treated female kidney transplant recipients: analysis of lymphocyte subpopulations and immunoglobulin serum levels. Transplantation 2000;69:2049-2054
10. Pilarski LM, Yacyshyn BR, Lazarovits AI. Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or to azathioprine in utero. Transplantation 1994;57:133-144
11. Airo P, Antonioli CM, Motta M, et al. The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/ polymyositis. Lupus 2002;11:454-457
12. Cimaz R, Meregalli E, Biggioggero M, et al. Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy. Toxicol Lett 2004;149:155-162
13. Meregalli E, Biggioggero M, Borghi O, Meroni P, Cimaz R. In vivo effects of maternal immunosuppression during pregnancy on the immune function of newborn infants. Arh Hig Rada Toksikol 2005;56:151-156
14. Airo P, Scarsi M, Brucato A, et al. Characterization of T-cell population in children with prolonged fetal exposure to dexamethasone for anti-Ro/SS-A antibodies associated congenital heart block. Lupus 2006;15:553-561
15. Cimaz R, Meregalli E, Biggioggero M, et al. Response to tetanus vaccination in infants exposed in utero to immunosuppressants for maternal autoimmune disorders. Lupus 2007;16:129-132
16. Marconi M, Plebani A, Avanzini MA, et al. ILIO and IL4 co-operate to normalize in vitro IgA production in IgA-deficient (IgAD) patients. Clin Exp Immunol 1998;112:528-532
17. Flechner SM, Katz AR, Rogers AJ, Van Buren C, Kahan BD. The presence of cyclosporine in body tissues and fluids during pregnancy. Am J Kidney Dis 1985;5:60-63
18. Venkataramanan R, Koneru B, Wang CC, Burckart GJ, Caritis SN, Starzl TE. Cyclosporine and its metabolites in mother and baby. Transplantation 1988;46:468-469
19. Coté CJ, Meuwissen HG, Pickering RJ. Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy. J Pediatr 1974;85:324-328
20. DeWitte DB, Buick MK, Cyran SE. Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone. J Pediatr 1984;105:625-628
21. Davison JM, Dellagrammatikas H, Parkin JM. Maternal azathioprine therapy and depressed hemopoiesis in the babies of renal allograft patients. Br J Obstet Gynaecol 1985;92:233-239
22. Jenkins MK, Schwartz H, Pardoll DM. Effect of Ciclosporin A on T cell development and clonal delection. Science 1988;241:1655-1658
23. Fukuzawa M, Sharrow SO, Shearer GM. Effect of Ciclosporin A on T cell immunity. Defective thymic education of CD4 T helper cell function in Ciclosporin A-treated mice. Eur J Immunol 1989;19:1147-1152
24. Halloran PF, Madrenas J. The mechanism of action of cyclosporine: a perspective for the 90's. Clin Biochem 1991;24:3-7
25. Ramsey-Goldman R, Schilling E. Immunosuppressive drug use during pregnancy. Rheum Dis Clin North Am 1997;23:149-167
26. Little BB. Immunosuppressant therapy during gestation. Semin Perinatol 1997;21:143-148
27. Bermas BL, Hill JA. Effects of immunosuppressive drugs during pregnancy. Arthritis Rheum 1995;38:1722-1732
28. Fox R. Antimalarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development. Lupus 1996;5:S4-S10
29. Baxter JD, Forsham PH. Tissue effects of glucocorticoids. Am J Med 1972;53:573-589
30. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids. New Mechanisms for old drugs. N Engl J Med 2005;353:1711-1723